Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

An observational study suggests coprescription of Phosphodiesterase Type 5 Inhibitors (i.e., sildenafil) and oral Nitrates is not associated with increased risk of adverse cardiovascular outcomes in male patients with ischemic heart disease.

20 Apr, 2022 | 10:11h | UTC

Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease: A Case-Crossover Study – Annals of Internal Medicine

Commentaries:

PDE5 inhibitors didn’t increase cardiovascular events in men on nitrates for heart disease – ACP Internist

PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD – HealthDay

 

RCT: Substrate ablation vs. antiarrhythmic drug therapy for symptomatic ventricular tachycardia.

20 Apr, 2022 | 09:46h | UTC

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Podcast: Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

 

Review | Blood pressure and its variability: classic and novel measurement techniques.

20 Apr, 2022 | 09:42h | UTC

Blood pressure and its variability: classic and novel measurement techniques – Nature Reviews Cardiology (if the link is paywalled, try this one)

 

Cohort Study: Infertility in women linked to increased risk of heart failure with preserved ejection fraction.

20 Apr, 2022 | 09:44h | UTC

Infertility and Risk of Heart Failure in the Women’s Health Initiative – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Podcast: Infertility and Risk of Heart Failure in the Women’s Health Initiative

Commentaries:

Infertility in Women Linked to Subsequent Risk of HFpEF – TCTMD

MGH study finds infertility associated with increased risk of heart failure – MedicalResearch

 

Evaluation of the causes of sex disparity in heart failure trials.

20 Apr, 2022 | 09:41h | UTC

Evaluation of the causes of sex disparity in heart failure trials – Heart

 

Commentary on Twitter

Images and article under a http://creativecommons.org/licenses/by-nc/4.0/ license

 

AHA Scientific Statement: Management of hypertension in patients with ventricular assist devices.

19 Apr, 2022 | 02:09h | UTC

Management of Hypertension in Patients With Ventricular Assist Devices: A Scientific Statement From the American Heart Association – Circulation: Heart Failure

 

Network M-A: Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes.

19 Apr, 2022 | 01:16h | UTC

Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis – openheart

 

M-A: Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination.

18 Apr, 2022 | 10:32h | UTC

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis – The Lancet Respiratory Medicine

Commentaries:

Myopericarditis following COVID-19 vaccination is rare, finds international study – The Lancet

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented – The Lancet Respiratory Medicine

Study explores myopericarditis incidence and COVID-19 vaccination – News Medical

 

Commentary on Twitter

 

AHA Scientific Statement: Nonalcoholic fatty liver disease and cardiovascular risk.

18 Apr, 2022 | 10:37h | UTC

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology

News Releases:

About 1 in 4 adults has an often-missed liver disorder linked to higher heart disease risk – American Heart Association

Fatty liver disease not caused by alcohol is common – and often missed – American Heart Association

 

RCT: Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people.

18 Apr, 2022 | 10:01h | UTC

Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial – European Heart Journal

Editorial: Pointing a FINGER at the contribution of lifestyle to cardiovascular events and dementia

 

Commentary on Twitter

 

Expert Analysis: The role of the posterior left pericardiotomy in reducing pericardial effusion and postoperative atrial fibrillation after cardiac surgery.

14 Apr, 2022 | 08:45h | UTC

The Role of the Posterior Left Pericardiotomy in Reducing Pericardial Effusion and Postoperative Atrial Fibrillation After Cardiac Surgery – American College of Cardiology

Related study from the same authors: #AHA21 – RCT: Among patients undergoing cardiac surgery, routine posterior left pericardiotomy can prevent postoperative atrial fibrillation.

 

Commentary on Twitter

 

M-A: Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy.

14 Apr, 2022 | 08:09h | UTC

Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis – openheart

 

Review: Diagnosis and treatment of pulmonary arterial hypertension.

13 Apr, 2022 | 10:58h | UTC

Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review – JAMA (free for a limited period)

Audio Clinical Review: Diagnosis and Treatment of Pulmonary Arterial Hypertension – JAMA

 

Commentary on Twitter

 

RCT: A home-based, walking exercise behavior change intervention increased walking distance in adults with peripheral artery disease.

13 Apr, 2022 | 11:02h | UTC

Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial – JAMA (free for a limited period)

 

Commentary on Twitter

 

M-A: Sodium-glucose Cotransporter 2 inhibitors are associated with reduced risk of hyperkalemia in people with type 2 diabetes.

13 Apr, 2022 | 10:52h | UTC

Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials – Circulation

 

Cohort Study: Increased thoracic aortic diameter is associated with increased risk of cardiovascular events and mortality among women and men.

13 Apr, 2022 | 10:20h | UTC

Thoracic Aortic Diameter and Cardiovascular Events and Mortality among Women and Men – Radiology

News Release: Increased aortic diameter raises risk of heart attack, stroke – Radiological Society of North America

 

Brief review | Infective endocarditis: words of caution for management.

13 Apr, 2022 | 10:12h | UTC

Infective Endocarditis: Words of Caution For Management – American College of Cardiology

Related:

Randomized Trial: Partial Oral vs. Intravenous Antibiotic Treatment of Endocarditis

Cohort Study: Socio-economic variations determine the clinical presentation, etiology and outcome of infective endocarditis.

Podcast: Infective Endocarditis Pearls.

AHA Statement: Prevention of Viridans Group Streptococcal Infective Endocarditis – Antibiotic prophylaxis for invasive dental procedures is suggested only for high-risk patients with the following conditions: 1) cardiac prosthetic valve; 2) previous infective endocarditis; 3) congenital heart disease; or 4) previous heart transplant

New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis

Review: Infective endocarditis after surgical and transcatheter aortic valve replacement

Infective Endocarditis: A Contemporary Review

Summary: Current AATS Guidelines on Surgical Treatment of Infective Endocarditis

Review: Current Evidence on Oral Antibiotics for Infective Endocarditis

[Abstract Only] Prevalence of Infective Endocarditis in Patients with Positive Blood Cultures According to the Organism

Observational Study Suggests Early Surgery is Associated with Reduced Mortality in Patients with Infective Endocarditis and Large Vegetation

Research: Invasive Procedures Associated With the Development of Infective Endocarditis

Meta-Analysis: Association of Vegetation Size With Embolic Risk in Patients With Infective Endocarditis

Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement

 

Interplay of mineralocorticoid receptor antagonists and Empagliflozin in heart failure: Secondary analysis of the EMPEROR-Reduced trial.

13 Apr, 2022 | 10:14h | UTC

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced – Journal of the American College of Cardiology

Editorial: Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care

 

RCT: Prophylactic Rivaroxaban for 30 days to prevent left ventricular thrombus after anterior ST-Segment Elevation Myocardial Infarction.

13 Apr, 2022 | 09:56h | UTC

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)

 

Study identifies which treatments are associated with an increased risk of heart disease among women with breast cancer.

13 Apr, 2022 | 10:00h | UTC

Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Major study links breast cancer treatment with increased risk of cardiovascular disease – Fred Hutch

 

Commentary on Twitter

 

Review | PCI in patients with heart failure: current evidence, impact of complete revascularization, and contemporary techniques to improve outcomes.

13 Apr, 2022 | 09:57h | UTC

PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes – JSCAI

 

Commentary on Twitter

(Images and article under a CC BY 4.0 Licence)

 

M-A: SGLT2 inhibitors reduce hospitalizations in patients with heart failure regardless of the presence of diabetes.

12 Apr, 2022 | 10:05h | UTC

Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: SGLT2 inhibitors reduces hospitalization for heart failure regardless of presence of diabetes – American College of Physicians

 

AHA Scientific Statement: SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults.

12 Apr, 2022 | 09:59h | UTC

SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association – Circulation

News Release: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association

Commentary: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD

 

Aspirin for primary cardiovascular prevention in patients with diabetes: uncertainties and opportunities.

12 Apr, 2022 | 08:45h | UTC

Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities – Thrombosis and Haemostasis

Related Guideline:

USPSTF draft statement revises previous guidance and now recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults aged 60 years or older.

Related Randomized Trials:

Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease

Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes

Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

Related Meta-Analysis:

Meta-Analysis: Association of Aspirin Use for Primary Prevention with Cardiovascular Events and Bleeding Events

Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups – BMC Medicine

Related Opinions:

Aspirin for Primary Prevention: Is This the End of the Road?

Evidence evolving on aspirin as prevention – ACP Internist

 

Editorial | Who? When? Where? How? Still the alpha and omega of extracorporeal cardiopulmonary resuscitation.

12 Apr, 2022 | 08:49h | UTC

Who? When? Where? How? Still the alpha and omega of extracorporeal cardiopulmonary resuscitation – European Heart Journal. Acute Cardiovascular Care

Original Study: The association between time to extracorporeal cardiopulmonary resuscitation and outcome in patients with out-of-hospital cardiac arrest – European Heart Journal. Acute Cardiovascular Care (link to abstract – $ for full-text)

Related:

RCT: In patients with refractory out-of-hospital cardiac arrest, a strategy of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment did not significantly improve survival with a favorable neurological outcome (OR 1.63; 95% CI 0.93 to 2.85; P = .09).

Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications.

Guidelines for extracorporeal cardiopulmonary resuscitation in children and adults

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.